Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

40.80USD
20 Sep 2018
Change (% chg)

-- (--)
Prev Close
$40.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,242
52-wk High
$54.45
52-wk Low
$12.75

Chart for

About

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for patients with severe and life-threatening diseases. The Company operates through the business of developing and commercializing therapeutics segment. The Company is focused on developing allogeneic or... (more)

Overall

Beta: 2.54
Market Cap(Mil.): $1,849.98
Shares Outstanding(Mil.): 45.34
Dividend: --
Yield (%): --

Financials

  ATRA.OQ Industry Sector
P/E (TTM): -- 107.68 32.65
EPS (TTM): -4.37 -- --
ROI: -45.47 1.61 12.72
ROE: -47.13 0.32 14.84

BRIEF-Atara Biotherapeutics Reports Q1 Loss Per Share $1.05

* ATARA BIOTHERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT OPERATIONAL PROGRESS

May 08 2018

BRIEF-Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration

* ATARA BIOTHERAPEUTICS EXPANDS T-CELL IMMUNOTHERAPY COLLABORATION TO ADVANCE NEXT-GENERATION CAR T TECHNOLOGIES IN ONCOLOGY, AUTOIMMUNE AND OTHER DISEASES Source text for Eikon: Further company coverage:

May 08 2018

Competitors

  Price Chg
Biogen Inc (BIIB.OQ) $341.24 --
Bayer AG (BAYGn.DE) €76.14 +0.32
Bayer AG (BAYE.F) -- --
Teva Pharmaceutical Industries Limited (TEVA.TA) 8,848.00 +187.00
Merck KGaA (MRCG.DE) €87.00 +0.30
Sanofi SA (SASY.PA) €74.64 -0.03
Novartis AG (NOVN.S) CHF81.56 -0.38
Roche Holding Ltd. (ROG.S) CHF235.45 +0.40
Roche Holding Ltd. (RO.S) CHF237.00 +0.40

Earnings vs. Estimates